Key result
[(123)I]IMTO imaging differentiated adrenocortical tumors from nonadrenocortical lesions with 89% sensitivity and 85% specificity.
Why the study?
Does [(123)I]IMTO imaging accurately characterize adrenal lesions in patients with adrenal masses?
Observational (n=51)
No
Does [(123)I]IMTO imaging accurately characterize adrenal lesions in patients with adrenal masses?
[(123)I]IMTO SPECT/CT imaging provides high sensitivity and specificity for noninvasively differentiating adrenocortical tumors from nonadrenocortical lesions.
No takes yet. Share an insight, caveat, or question.
Supports further evaluation of [(123)I]IMTO imaging; leaves open its clinical utility pending larger validation studies.
Hahner et al. (2013) conducted an observational in Adrenal lesions (n=51). [(123)I]IMTO imaging was evaluated on Sensitivity and specificity for the noninvasive characterization of adrenal lesions. [(123)I]IMTO imaging differentiated adrenocortical tumors from nonadrenocortical lesions with 89% sensitivity and 85% specificity.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: